Clinical Trial Update: Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood [Phase 1, Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update describes a Phase 1/Phase 2 trial evaluating the safety and efficacy of quizartinib in children and young adults with acute myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Quizartinib (Quizartinib)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING